Showing results (11-20 of 3,810) with videos related to
Sort By:
Pageof 381
The American Journal of Medicine|January 21, 1985
Pharmaco-epidemiology--drugs, arthritis, and neoplasms: industry contribution to the dataH H Tilson, J WhisnantNeuropeptides|October 1, 1986
Behavioral effects of centrally administered dynorphin and [D-ala2-D-leu] enkephalin (DADLE) in ratsH Tilson, R McLamb, J HongAmerican Journal of Preventive Medicine|September 25, 2001
Public health physicians: an endangered speciesH H Tilson, K M GebbieLife Sciences|October 3, 1983
Long-term effects of behavioral testing on serum hormones and brain weightL Uphouse, H Tilson, C L MitchellHealth Affairs (Project Hope)|November 22, 2002
The public health workforceKristine Gebbie, Jacqueline Merrill, Hugh H TilsonPharmacoepidemiology and Drug Safety|September 27, 2005
Defining the competencies of those conducting pharmacovigilanceBrian Edwards, Hugh H Tilson, Suzanne L WestLife Sciences|January 1, 1991
Age-related changes in receptor-mediated phosphoinositide hydrolysis in various regions of rat brainW Mundy, P Tandon, S Ali, et al.Environmental Health Perspectives|April 1, 1996
Risk assessment for neurobehavioral toxicity: SGOMSEC joint reportD Hattis, J Glowa, H Tilson, et al.Journal of Primary Care & Community Health|January 24, 2022
Use of a Research as Intervention Approach to Explore Telebehavioral Health Services During the COVID-19 Pandemic in Southeastern IdahoDiana C Schow, Ann Thomson, Wilson T Trusty, et al.Journal of Medical Virology|January 1, 1993
Safety of acyclovir: a summary of the first 10 years experienceH H Tilson, C R Engle, E B AndrewsPageof 381